Skip to main content

Patient Advocacy During the Pandemic

Web Exclusives - COVID-19

Patient advocacy organizations regularly field and fulfill requests for assistance from patients with a serious illness, such as cancer. In the face of COVID-19, such requests have increased exponentially. Ms Goldsmith and Mr Klein outlined their organizations’ efforts to meet patients’ needs.

“Many patients with cancer, chronic disease, or rare disease were already seriously challenged, and the COVID-19 pandemic has just added to that challenge,” said Mr Klein.

Ms Goldsmith agreed, saying that CancerCare has garnered recognition for its efforts after funding from Bristol-Myers Squibb and Merck allowed for the creation of a model disaster relief program in partnership with 18 organizations. Even with that foresight, however, CancerCare had not prepared for a pandemic, she said.

“To give you some sense of the magnitude of what the organization is experiencing, as of March 30, we received 6009 calls from individuals looking for guidance, practical assistance, and financial assistance,” Ms Goldsmith noted. “There is a lot of desperation out there,…I think even higher than the levels we experienced during 9/11.”

In response, CancerCare mobilized the 3 pillars of its organization: psychosocial support, education, and financial assistance. Along with creating a resource webpage on COVID-19 for patients and caregivers, CancerCare hosted a virtual workshop on the virus for people with cancer, she said. The organization also created a fund for patients with cancer undergoing treatment who have COVID-19. The fund provides $300 grants to offset living costs. The CancerCare Copayment Assistance Foundation has been inundated with requests.

At the end of March, CancerCare partnered with the LUNGevity Foundation to provide $500 grants to patients receiving active treatment for lung cancer. In addition, CancerCare launched a program to help patients cover pet expenses during treatment, so far disbursing more than $41,600.

The PAN Foundation has also been working hard to meet patients’ needs via the PAN COVID-19 Assistance Fund, which provides $300 grants to patients diagnosed with or who self-quarantine because of the novel coronavirus, Mr Klein said.

The goal of these programs is “to add additional support to patients who are already struggling with out-of-pocket costs and with access and affordability issues,” he said.

More than 85% of the PAN Foundation’s grant recipients are >300% below the federal poverty level and many are Medicare beneficiaries, so the organization is focused on copayment assistance, noting that House Speaker Nancy Pelosi has proposed “putting a moratorium on out-of-pocket costs during the pandemic.”

“Coupled now with the pandemic, the amount of financial burden that is hitting vulnerable patients is tremendous,” Mr Klein said.

Related Items
Peptide-Based CoVac-1 Vaccine Shows Promise Against COVID-19 in Patients with Cancer
JHOP - June 2022 Vol 12, No 3 published on June 16, 2022 in AACR Highlights, Vaccinations, COVID-19, Infections
Protecting Patients with Cancer During the COVID-19 Pandemic
Robert Mancini, PharmD, BCOP, FHOPA, Timothy G. Tyler, PharmD, FCSHP, FHOPA
JHOP - April 2022 Vol 12, No 2 published on April 26, 2022 in Editorial, COVID-19
Outcomes of Pharmacist-Provided Telehealth Services in an Ambulatory Oncology Clinic During the COVID-19 Pandemic
Colleen Bohnenkamp, PharmD, BCOP, BCPS, Grace A. Martin, PharmD, BCOP, Laure DuBois, PharmD, BCOP, Olivia Fahey, PharmD, BCOP, Jade Hefler, PharmD
JHOP - October 2021 Vol 11, No 5 published on October 29, 2021 in Original Article, Telehealth, COVID-19
Operation Angel on the Line: Oncology Pharmacist and Pharmacy Students Piloting a New Oral Chemotherapy Telehealth Clinic During the COVID-19 Pandemic
JHOP - March 2021 Vol 11 Special Feature published on April 9, 2021 in HOPA Abstracts, Chemotherapy, COVID-19
Webinar Panelist Discusses COVID-19 and Hematology Oncology Pharmacy
Web Exclusives published on August 11, 2020 in COVID-19
Potential for Anti-Cancer Agents in the Treatment of COVID-19
Web Exclusives published on July 20, 2020 in COVID-19
Oncology Home Infusions in the Post–COVID-19 World
Web Exclusives published on July 20, 2020 in COVID-19
Economic Impact of the COVID-19 Crisis
Web Exclusives published on June 2, 2020 in COVID-19
Actuarial View of COVID-19: Payers, Providers, and Healthcare Reform
Web Exclusives published on June 2, 2020 in COVID-19
Washington and COVID-19: The Government Response
Web Exclusives published on May 26, 2020 in COVID-19